Down-regulation of the TIMP2 gene in prostate cancer cells was shown to be associated with promoter methylation [13], suggesting that epigenetic regulatory factors, such as HDAC and DNMT, may be involved in regulation of TIMP2. Here, DNMT1 is linked to prostate carcinoma.